Vertex Pharmaceuticals Incorporated
(NASDAQ:VRTX)|
22.32 -1.02 (-4.37%) Dec 04 - Close |
|
|
|
After-Hours 22.39 +0.07 (0.31%) Thu, 4 Dec 2008 7:40 PM
- Compare VRTX with:
- View: Line | Candlestick
Company Profile
Vertex Pharmaceuticals Incorporated
130 Waverly Street
Cambridge, MA 02139-4242
United States - Map
Phone: (617) 444-6100
Fax: (617) 444-6680
Website: www.vpharm.com
State of incorporation: Massachusetts
CEO: Dr. Joshua S. Boger, Ph.D.
Employees: 1,132
Sector: Healthcare
Industry Group: Drugs
Industry: Drug Manufacturers - Other
Engaged in structure-based rational drug design
The Company is in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases.
Recent news for VRTX
-
Vertex Pharmaceuticals Announces Webcast of its Presentation at Two Investor Conferences
Business Wire - Nov 26 at 9:15 ET
-
Motley Fool - Nov 25 at 4:04 ET
-
Motley Fool - Nov 25 at 3:04 ET
-
Schering-Plough: The Reviews Are In
CNBC - Nov 25 at 11:23 ET
-
Coverage initiated on Vertex Pharm by Credit Suisse
Briefing.com - Nov 25 at 9:26 ET
-
Health Winners & Losers: Enzon
TheStreet.com - Nov 19 at 3:55 ET
-
Health Care Reform and Your Health Stocks
TheStreet.com - Nov 19 at 2:09 ET
-
[$$] Recession or Not, We Still Need Drugs
RealMoney by TheStreet.com - Nov 17 at 4:09 ET
-
Vertex Pharmaceuticals Announces Webcast of its Presentation at Two Investor Conferences
Business Wire - Nov 14 at 9:34 ET
-
[$$] Biotech Mailbag: Vertex Has Verve
RealMoney by TheStreet.com - Nov 14 at 7:02 ET
Top members owning VRTX
-
Top 4%
-39.35%3m:
-39.35%YTD:
-
Top 48%
-32.52%3m:
-41.59%YTD:
-
Top 52%
-34.83%3m:
-37.35%YTD: